Knoxville, TN
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Thompson Oncology Group, founded in 1995, is a mid-sized nonprofit in the Health Care sector that reported $22.2M in total revenue in fiscal year 2023. Revenue surged 74% from the prior year, signaling strong growth momentum. Expenses of $35.2M exceeded revenue, resulting in a 59% operating deficit.
Thompson Oncology Group is a multi-location physician practice focused on cancer care throughout East Tennessee. It is a member of the Covenant Health system.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $22,215,085 | $12,737,790 | +0.7% |
| Expenses | $35,226,900 | $26,311,885 | +0.3% |
| Net Income | $-13,011,815 | $-13,574,095 | 0.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Gerald Boyd | Director | 0.00 |
Director
|
$0 | $0 | $977 |
| Willard Campbell MD | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| Michael Casey MD | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| Ronni Chandler | Fmr Director (through June 2023) | 0.00 |
Director
|
$0 | $0 | $0 |
| Mitchell Dickson MD | Director | 0.00 |
Director
|
$0 | $0 | $796 |
| Stephanie Flood | Director | 0.00 |
Director
|
$0 | $0 | $808 |
| James Gibson | Director | 0.00 |
Director
|
$0 | $0 | $1,008 |
| Edgar Gray | Director | 0.00 |
Director
|
$0 | $0 | $1,054 |
| Leslye Hartsell | Director | 0.00 |
Director
|
$0 | $0 | $1,027 |
| Donald Hickman | Director | 0.00 |
Director
|
$0 | $0 | $1,498 |
| Timothy Matthews | Director | 0.00 |
Director
|
$0 | $0 | $1,196 |
| Janice McKinley | Director | 0.00 |
Director
|
$0 | $0 | $1,222 |
| Dave Miller | Director | 0.00 |
Director
|
$0 | $0 | $1,044 |
| Bill Myers | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| Alvin Nance | Director | 0.00 |
Director
|
$0 | $0 | $1,044 |
| Linda Ogle | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| King Purnell | Director/Chair | 0.00 |
Officer
Director
|
$0 | $0 | $1,630 |
| Jorge Sanabria | Director | 0.00 |
Director
|
$0 | $0 | $1,234 |
| William Seale | Director | 0.00 |
Director
|
$0 | $0 | $1,321 |
| Cosby Stone | Director | 0.00 |
Director
|
$0 | $0 | $1,595 |
| Joe Sutter | Director | 0.00 |
Director
|
$0 | $0 | $1,462 |
| James Tramontana MD | Director | 0.00 |
Director
|
$0 | $0 | $1,196 |
| James D VanderSteeg | President & CEO | 0.00 |
Officer
Director
|
$0 | $352,568 | $3,115,259 |
| John T Geppi | Fmr EVP/CFO (through June 2023) | 0.00 |
Officer
|
$0 | $24,345 | $995,771 |
| Joseph C Dolan | EVP/CFO | 0.00 |
Officer
|
$0 | $38,564 | $397,454 |
| R Scott Warwick | Fmr Pres & CAO (through July 2023) | 20.00 |
Officer
|
$0 | $19,525 | $380,237 |
| Benjamin J Devore | President & CAO | 20.00 |
Officer
|
$0 | $35,945 | $250,400 |
| Mitzi F Anderson | VP - Financial Services | 35.00 |
Officer
|
$0 | $27,391 | $173,002 |
| Thomas B Repine MD | Physician - Oncologist | 50.00 |
Highest
|
$975,422 | $47,901 | $1,023,323 |
| Namratha R Vontela MD | Physician - Oncologist | 50.00 |
Highest
|
$802,588 | $19,032 | $821,620 |
| Farrukh Ashraf MD | Physician - Oncologist | 50.00 |
Highest
|
$703,496 | $36,661 | $740,157 |
| David D Chism MD | Physician - Oncologist | 50.00 |
Highest
|
$697,227 | $51,841 | $749,068 |
| Michael R Thompson MD | Physician - Oncologist | 50.00 |
Highest
|
$678,498 | $37,914 | $716,412 |
| Lucas D Johnson Sr | Fmr Pres/CAO; Fmr EVP-Phys Ent | 0.00 |
|
$0 | $12,902 | $350,029 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $22,215,085 | $35,226,900 | $11,317,682 | $-13,011,815 |
| 2022 | $12,737,790 | $26,311,885 | $11,719,543 | $-13,574,095 |
| 2021 | $6,910,649 | $17,062,943 | $3,058,413 | $-10,152,294 |
| 2020 | $5,776,441 | $16,270,803 | $3,236,070 | $-10,494,362 |
| 2019 | $5,854,904 | $15,674,742 | $3,149,892 | $-9,819,838 |
| 2018 | $6,001,565 | $13,965,486 | $1,362,372 | $-7,963,921 |
Compare Thompson Oncology Group with other nonprofits in Tennessee and across the country.